Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maria Dolores Mediano"'
Autor:
Maria Dolores Mediano, Beatriz Jimenez Munarriz, Elena Vila-Navarro, Esther Noguerón, Carmen Beato, Fenor, Elena Mata, Antonio Viudez, Juan Francisco Rodriguez-Moreno, Elena Sevillano, Jesús García-Donas, Carmen Balana, L Miguel Navarro, Paloma Navarro, Francisco Zambrana, Gema Bruixola, Xabier Mielgo Rubio, Sergio Ruiz, José Luis Fuster, Juan Antonio Virizuela
Publikováno v:
Journal of Clinical Oncology. 37:3082-3082
3082 Background: Identification of “agnostic” genetic drivers in cancer is foreseen as a major step forward in precision medicine.Unfortunately, “off label” use of targeted therapies is not widely available and many oncogenic alteration do no
Autor:
Ana Nogal, Amparo Sanchez-Gastaldo, Beatriz Romero-Romero, Maria Dolores Mediano, Ricardo Melendez, Rocio Garcia-Carbonero, Sonia Molina-Pinelo, Luis Paz-Ares, José Luis López-Campos, Amancio Carnero, Maria Dolores Pastor
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 2, Pp 3440-3455 (2013)
International Journal of Molecular Sciences; Volume 14; Issue 2; Pages: 3440-3455
International Journal of Molecular Sciences
Digital.CSIC. Repositorio Institucional del CSIC
instname
idUS. Depósito de Investigación de la Universidad de Sevilla
International Journal of Molecular Sciences; Volume 14; Issue 2; Pages: 3440-3455
International Journal of Molecular Sciences
Digital.CSIC. Repositorio Institucional del CSIC
instname
idUS. Depósito de Investigación de la Universidad de Sevilla
Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) commonly coexist in smokers, and the presence of COPD increases the risk of developing LC. Cigarette smoke causes oxidative stress and an inflammatory response in lung cells, which in
Autor:
Alberto Torres-Zurita, Lucía Vázquez-Montero, Laura Gallego-López, María Dolores Mediano-Rambla, Luis de la Cruz-Merino
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Nowadays, immune checkpoint inhibitors (ICI) have become the cornerstone of treatment for many tumors, either as monotherapy or in combination with other therapies. However, these drugs are associated with several new side effects that need early det
Externí odkaz:
https://doaj.org/article/e7f8dded05b14850936d2a0a4f5514ca
Autor:
Miriam Alonso, Maria Dolores Mediano, Irene Ferrer, Amancio Carnero Moya, Maria Atienza, Jesus Corral Jaime, Nicolas Moreno, Sonia Molina-Pinelo, Luis Paz-Ares
Publikováno v:
Journal of Clinical Oncology. 33:e18501-e18501
e18501 Background: Only the 23% of NSCLC patients (pts) are discovered in potential curable disease. Even radical surgery, the 50% of pts will develop metastases, so adjuvant chemotherapy is recomm...
Autor:
Marta Amerigo, Maria Dolores Mediano, Amparo Sanchez Gastaldo, Miriam Crespo Alonso, Carlos Enrique Robles, Miriam Gonzalez de la Peña, Jesus Corral Jaime
Publikováno v:
Journal of Clinical Oncology. 31:e19160-e19160
e19160 Background: Lung cancer is the leading cause of cancer-related deaths globally, with a 15% 5-year survival rate. Platinum-based chemotherapy constitutes the main treatment modality, with a median overall survival (OS) of approximately 10–12